"Pfizer directors worry the company's shares, now trading at a 10½-year low of $19.18, would plunge to $10 or $12."
Story in the Wall Street Journal.
My prediction: Jeff Kindler will be gone within five years, unless he makes another major acquisition.
And another one.
And another one . . .